Press Room

American Cancer Society Cancer Action Network (ACS CAN) volunteers will head to Capitol Hill today with over 100 other cancer patients, survivors, caregivers, physicians and researchers representing more than 50 cancer organizations to share poll results that show overwhelming public support for continued robust and sustained federal investment in cancer research and urge lawmakers to make fighting cancer a top national priority.

Proposals expected to be announced as part of the administration's American Patients First plan, include various changes to Medicare’s prescription drug program, such as protecting beneficiaries from catastrophic costs through an out-of-pocket maximum, and requiring plans to share a minimum portion of drug rebates with patients.

Washington, D.C. - Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics

Statement of the American Cancer Society, American Heart Association, American Lung Association, Americans for Nonsmokers’ Rights, National African American Tobacco Prevention Network and the Tobacco-Free Kids Action Fund (public health intervenors in the case)

Advocates from the American Cancer Society Cancer Action Network (ACS CAN) will be on Capitol Hill today asking Congress to support initiatives that would increase research and improve treatment for children with cancer.

WASHINGTON, D.C. – Today the Senate Health, Education, Labor and Pensions Committee (HELP) marked up the Opioid Crisis Response Act of 2018.

More than 100 organizations representing millions of patients, providers and consumers joined together in letters and formal comments to Congressional leadership and federal agencies urging the withdrawal of a proposed rule on short-term, limited duration insurance plans (STLD).

oday the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department of Health and Human Services (HHS) on proposed changes to rules governing short-term, limited duration insurance plans (STLD). The comments detail how the proposed rule could divide the individual insurance market and significantly weaken patient protections, leaving cancer patients and survivors with few meaningful or affordable coverage choices.

WASHINGTON, D.C. – Six leading public health and medical organizations today urged the U.S.

The American Cancer Society Cancer Action Network (ACS CAN) today released a report examining the most common patient barriers to cancer clinical trial enrollment. Made public at ACS CAN’s annual national policy forum, the report found only about one in four (27%) patients has access to clinical trials where they are being treated. Yet, if asked to enroll in an available trial, more than half of eligible patients typically agree to do so.